LTHO Stock Overview
Legacy Technology Holdings, Inc. develops and commercializes a web-based genomic preventative medicine and medical software solution.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Legacy Technology Holdings, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.06 |
52 Week High | US$0.06 |
52 Week Low | US$0.06 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -25.00% |
5 Year Change | n/a |
Change since IPO | -90.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
LTHO | US Healthcare Services | US Market | |
---|---|---|---|
7D | 0% | 2.1% | 2.3% |
1Y | n/a | -3.0% | 26.8% |
Return vs Industry: Insufficient data to determine how LTHO performed against the US Healthcare Services industry.
Return vs Market: Insufficient data to determine how LTHO performed against the US Market.
Price Volatility
LTHO volatility | |
---|---|
LTHO Average Weekly Movement | n/a |
Healthcare Services Industry Average Movement | 10.7% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.3% |
10% least volatile stocks in US Market | 2.8% |
Stable Share Price: LTHO has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine LTHO's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2012 | n/a | n/a | www.genomics-giws.com |
Legacy Technology Holdings, Inc. develops and commercializes a web-based genomic preventative medicine and medical software solution. It uses algorithms to analyze data on individual patient lifestyle factors, such as blood tests, biometrics, diet, environmental, nutraceutical, pharmaceutical, and genetic makers. The company was incorporated in 2012 and is based in Arvada, Colorado .
Legacy Technology Holdings, Inc. Fundamentals Summary
LTHO fundamental statistics | |
---|---|
Market cap | US$4.36m |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs LTHO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LTHO income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did LTHO perform over the long term?
See historical performance and comparison